Financière de Tubize S.A.
TUB
Hisse Senetlerindeki Sıralama
#2119
Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a... Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a global biopharmaceutical firm, primarily through its investment in UCB. The company is dedicated to discovering and advancing innovative medicines and solutions focused on neurological and immunological disorders. Its current commercial offerings include Cimzia, an established treatment for a range of inflammatory conditions such as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis. For partial-onset seizures in epilepsy, it provides Briviact, Vimpat, and Keppra, alongside Nayzilam, a nasal spray. Neupro addresses Parkinson's disease and restless legs syndrome. Additionally, the portfolio features Evenity, an injectable therapy for osteoporosis, and Bimzelx, used to manage moderate to severe plaque psoriasis. The company's development pipeline highlights several promising candidates: Staccato, aimed at stereotypical prolonged seizures; Bepranemab for Alzheimer's disease; and UCB0599 for Parkinson's disease. Other therapies under investigation include bimekizumab, which targets psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab, for conditions like myasthenia gravis, immune thrombocytopenia, myelin oligodendrocyte glycoprotein antibody disease, and autoimmune encephalitis; and dapirolizumab pegol, intended for systemic lupus erythematosus.
Hisse Fiyatı
$217.90
Piyasa Değeri
$9.70B
Değişim (1 gün)
5.57%
Değişim (1 yıl)
-20.53%
Ülke
BE
Ticaret Financière de Tubize S.A. (TUB)
Kategori
Healthcare
Financière de Tubize S.A. (TUB) için temettü geçmişi
Financière de Tubize S.A. (hisse sembolü: TUB) toplam 26 temettü ödemesi yaptı.
Tüm temettülerin toplamı (hisse bölünmeleriyle ayarlanmış): $13.63
Temettü verimi (TTM): 0.0065
Tüm temettülerin toplamı (hisse bölünmeleriyle ayarlanmış): $13.63
Temettü verimi (TTM): 0.0065
Financière de Tubize S.A. (TUB) için 2000 ile 2026 arasındaki temettü ödemeleri
Yıllık temettü ödemeleri
| Yıl | Temettü (hisse bölünmesiyle ayarlanmış) | Değiştir |
|---|---|---|
| 2026 (TTM) | $0.8945 | 0.00% |
| 2025 | $0.8945 | -7.78% |
| 2024 | $0.97 | 12.79% |
| 2023 | $0.86 | 14.67% |
| 2022 | $0.75 | 10.29% |
| 2021 | $0.68 | 9.68% |
| 2020 | $0.62 | 10.71% |
| 2019 | $0.56 | 3.70% |
| 2018 | $0.54 | 3.85% |
| 2017 | $0.52 | 4.00% |
| 2016 | $0.5 | 4.17% |
| 2015 | $0.48 | 0.00% |
| 2014 | $0.48 | 0.00% |
| 2013 | $0.48 | 0.00% |
| 2012 | $0.48 | 0.00% |
| 2011 | $0.48 | 0.00% |
| 2010 | $0.48 | 0.00% |
| 2009 | $0.48 | 1.42% |
| 2008 | $0.4733 | 2.16% |
| 2007 | $0.4633 | 2.21% |
| 2006 | $0.4533 | 3.02% |
| 2005 | $0.44 | 6.46% |
| 2004 | $0.4133 | 8.76% |
| 2003 | $0.38 | 21.29% |
| 2002 | $0.3133 | 23.69% |
| 2001 | $0.2533 | 35.67% |
| 2000 | $0.1867 | 0.00% |
Tüm temettü ödemelerinin listesi
| Yıl | Temettü | Değiştir |
|---|---|---|
| 2026 (TTM) | $0.8945 | 0.00% |
| 2025 | $0.8945 | -7.78% |
| 2024 | $0.97 | 12.79% |
| 2023 | $0.86 | 14.67% |
| 2022 | $0.75 | 10.29% |
| 2021 | $0.68 | 9.68% |
| 2020 | $0.62 | 10.71% |
| 2019 | $0.56 | 3.70% |
| 2018 | $0.54 | 3.85% |
| 2017 | $0.52 | 4.00% |
| 2016 | $0.5 | 4.17% |
| 2015 | $0.48 | 0.00% |
| 2014 | $0.48 | 0.00% |
| 2013 | $0.48 | 0.00% |
| 2012 | $0.48 | 0.00% |
| 2011 | $0.48 | 0.00% |
| 2010 | $0.48 | 0.00% |
| 2009 | $0.48 | 1.42% |
| 2008 | $0.4733 | 2.16% |
| 2007 | $0.4633 | 2.21% |
| 2006 | $0.4533 | 3.02% |
| 2005 | $0.44 | -46.78% |
| 2004 | $0.8267 | 8.78% |
| 2003 | $0.76 | 21.27% |
| 2002 | $0.6267 | 23.68% |
| 2001 | $0.5067 | 35.74% |
| 2000 | $0.3733 | 0.00% |
Benzer şirketler veya rakipler için temettü ödemeleri
| Şirket | Temettü ödemesi sayısı | Ülke |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 64.00% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
